MedPath

Population pharmacokinetic-pharmacodynamic model of general anesthesia for propofol, sufentanil and atracurium, considering the propofol exhaled air concentration and EEG (BIS)

Conditions
Patients undergoing elective surgery who have an indication to use arterial blood pressure monitoring.
Registration Number
DRKS00017026
Lead Sponsor
niversitätsklinikum des Saarlandes
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
35
Inclusion Criteria

Written consent of the patient; Electively operated patients under general anesthesia; The indication due to surgery and / or anesthesia to establish arterial blood pressure monitoring

Exclusion Criteria

Intolerance to propofol, sufentanil or atracurium; Children and adolescents (<18 years of age); Patients undergoing emergency surgery; Drug abuse; Positive HIV test; Positive hepatitis test; Pregnancy; Patients in whom the indication for anesthesia with volatile anesthetics is made; Patients who are not indicated to use arterial blood pressure monitoring; Rejection by the patient

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Model parameters with inter- and intraindividual variability (variance) for compartment volumes, clearances and transfer constants of a population-pharmacokinetic-pharmacodynamic model of general anesthesia for propofol, sufentanil and atracurium taking into account the EEG (bispectral index)
Secondary Outcome Measures
NameTimeMethod
Investigation of the influence of co-variables on parameters within the pharmacokinetic model.
© Copyright 2025. All Rights Reserved by MedPath